Macleods Pharma USA recalls over 3,700 bottles of blood pressure pills
仅事实

Macleods Pharma USA recalls over 3,700 bottles of blood pressure pills

摘要

The FDA classified the recall as Class II after a quality test showed the generic Olmesartan-Amlodipine-Hydrochlorothiazide tablets failed dissolution specifications.

Macleods Pharma USA, based in New Jersey, announced a voluntary recall of two lot numbers of its generic combination blood-pressure medication containing Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide. The FDA issued a Class II recall on Oct. 27, indicating the product could cause reversible side effects and, in rare cases, more serious effects.

The recall affects 3,700 bottles – one 90-count and one 30-count – that did not meet dissolution specifications, meaning the tablets may not release their active ingredients properly. The affected lot numbers are 12251163A and 12251163B, with national drug codes 33342-246-10 for the 90-count bottle and 33342-246-07 for the 30-count bottle. The medication expires on May 31, 2027.

Consumers are advised to check the lot number and NDC on their pill bottles. If the numbers do not match the recalled lots, AARP recommends contacting the pharmacy for guidance. The FDA has not issued recalls for the brand-name equivalents, such as Tribenzor or Benicar HCT.

Macleods did not respond to a request for comment, and it was not confirmed whether any of the recalled bottles were distributed on Long Island.

来源

Newsday

继续阅读——免费

创建免费账户以关注新闻。无需银行卡。